Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles

Background: Atopic dermatitis is a chronic, noncontiguous, and exudative disorder accompanied by perivascular infiltration of immune mediators, including T-helper (Type 1 helper/Type 2 helper) cells, mast cells, and immunoglobulin E. The current study explores the immunomodulatory and histological e...

Full description

Bibliographic Details
Published in:International Journal of Nanomedicine
Main Author: Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S.
Format: Article
Language:English
Published: Dove Medical Press Ltd. 2014
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908519237&doi=10.2147%2fIJN.S71543&partnerID=40&md5=5c5d19b030efb834ad52da46a75ec71d
id 2-s2.0-84908519237
spelling 2-s2.0-84908519237
Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S.
Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles
2014
International Journal of Nanomedicine
9
1
10.2147/IJN.S71543
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908519237&doi=10.2147%2fIJN.S71543&partnerID=40&md5=5c5d19b030efb834ad52da46a75ec71d
Background: Atopic dermatitis is a chronic, noncontiguous, and exudative disorder accompanied by perivascular infiltration of immune mediators, including T-helper (Type 1 helper/Type 2 helper) cells, mast cells, and immunoglobulin E. The current study explores the immunomodulatory and histological effects of nanoparticle (NP)-based transcutaneous delivery of hydrocortisone (HC).; Methods: In this study, HC, the least potent topical glucocorticoid, was administered transcutaneously as chitosan NPs. The pharmacological and immunological effects of the NP-based HC delivery on the alleviation of 2, 4-dinitrofluorobenzene-induced atopic dermatitis (AD)-like skin lesions were evaluated using the NC/Nga mouse model.; Results: In vivo Dino-Lite® microscopic assessment revealed that the NP-based formulation displayed a remarkable ability to reduce the severity of the pathological features of AD (dermatitis index, 3.0). The AD suppressive activity of the NP-based topical formulation was expected owing to the interruption of a series of immunopathological events, including the production of immunoglobulin E, release of histamine, and expression of prostaglandin-E2 and vascular endothelial growth factor-α in the sera and skin of the tested animals. Analysis of the cytokine expression in AD-like skin lesions further revealed that the NP-based formulation inhibited the pathological expression of interleukin (IL)-4, IL-5, IL-6, IL-13, IL-12p70, interferon-γ, and tumor necrosis factor-α in serum and skin homogenates of NC/Nga mice. Further, our histological findings indicated that the NP-based formulation inhibited fibroblast infiltration and fragmentation of elastic fibers, further supporting the clinical importance of these formulations in maintaining the integrity of elastic connective tissues.; Conclusion: The current investigation suggests that NP-mediated transcutaneous delivery of HC could be considered an effective therapeutic approach to manage dermatitis. © 2014 Hussain et al.
Dove Medical Press Ltd.
11769114
English
Article
All Open Access; Gold Open Access; Green Open Access
author Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S.
spellingShingle Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S.
Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles
author_facet Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S.
author_sort Hussain Z.; Katas H.; Amin M.C.I.M.; Kumolosasi E.; Sahudin S.
title Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles
title_short Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles
title_full Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles
title_fullStr Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles
title_full_unstemmed Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles
title_sort Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisoneloaded chitosan nanoparticles
publishDate 2014
container_title International Journal of Nanomedicine
container_volume 9
container_issue 1
doi_str_mv 10.2147/IJN.S71543
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908519237&doi=10.2147%2fIJN.S71543&partnerID=40&md5=5c5d19b030efb834ad52da46a75ec71d
description Background: Atopic dermatitis is a chronic, noncontiguous, and exudative disorder accompanied by perivascular infiltration of immune mediators, including T-helper (Type 1 helper/Type 2 helper) cells, mast cells, and immunoglobulin E. The current study explores the immunomodulatory and histological effects of nanoparticle (NP)-based transcutaneous delivery of hydrocortisone (HC).; Methods: In this study, HC, the least potent topical glucocorticoid, was administered transcutaneously as chitosan NPs. The pharmacological and immunological effects of the NP-based HC delivery on the alleviation of 2, 4-dinitrofluorobenzene-induced atopic dermatitis (AD)-like skin lesions were evaluated using the NC/Nga mouse model.; Results: In vivo Dino-Lite® microscopic assessment revealed that the NP-based formulation displayed a remarkable ability to reduce the severity of the pathological features of AD (dermatitis index, 3.0). The AD suppressive activity of the NP-based topical formulation was expected owing to the interruption of a series of immunopathological events, including the production of immunoglobulin E, release of histamine, and expression of prostaglandin-E2 and vascular endothelial growth factor-α in the sera and skin of the tested animals. Analysis of the cytokine expression in AD-like skin lesions further revealed that the NP-based formulation inhibited the pathological expression of interleukin (IL)-4, IL-5, IL-6, IL-13, IL-12p70, interferon-γ, and tumor necrosis factor-α in serum and skin homogenates of NC/Nga mice. Further, our histological findings indicated that the NP-based formulation inhibited fibroblast infiltration and fragmentation of elastic fibers, further supporting the clinical importance of these formulations in maintaining the integrity of elastic connective tissues.; Conclusion: The current investigation suggests that NP-mediated transcutaneous delivery of HC could be considered an effective therapeutic approach to manage dermatitis. © 2014 Hussain et al.
publisher Dove Medical Press Ltd.
issn 11769114
language English
format Article
accesstype All Open Access; Gold Open Access; Green Open Access
record_format scopus
collection Scopus
_version_ 1809677609412329472